FDA grants IDE to SpinaFX for study of Triojection
The planned trial is expected to include 300 participants across two treatment arms.
News
Gore secures CE Mark for venous stent to treat inferior vena cava
Stevanato unveils Deora pen injector for diabetes and weight management
Tandem secures CE mark for AID systems in T2D and T1D with pregnancy
Medtronic secures CE mark for Stealth AXiS system for ENT surgery
Insulet reports new data for Omnipod 6 and FCL systems
Roche develops RUO PCR assay to detect rare Ebola Bundibugyo virus
FDA approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 software
